{
    "root": "350884ec-5351-1828-e063-6294a90a2c10",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Methimazole",
    "value": "20250513",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "METHIMAZOLE",
            "code": "554Z48XN5E"
        }
    ],
    "indications": "Methimazole tablets are indicated:\n                  \n                     In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.\n                     To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.",
    "contraindications": "Methimazole tablets are administered orally. The total daily dosage is usually given in 3 divided doses at approximately 8-hour intervals.\n                  \n                     \n                        Adult\n                     - The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily.\n\n \n                  \n                  \n                     \n                        Pediatric\n                     - Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.",
    "warningsAndPrecautions": "Methimazole Tablets, USP 10 mg - White to off-white, round tablets debossed with \"656\" on one side and \"B/P\" on the other side.\n                  \n                     NDC 71335-2218-1: 30 Tablets in a BOTTLE\n                     NDC 71335-2218-2: 15 Tablets in a BOTTLE\n                     NDC 71335-2218-3: 90 Tablets in a BOTTLE\n                  \n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].\n                  Dispense in tight, light-resistant container.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions": "Methimazole tablets are contraindicated in the presence of hypersensitivity to the drug or any of the other product components."
}